Introduction -The first sentence is very unclear and should be removed or reworded. Who holds this growing concern? The public? Participants -were the 3 demographic characteristics the only ones collected? What about ethnicity and education? These are certainly not exhaustive for representativeness and could be seen as a limitation, or acknowledged as one. For Table 2 Were they asked to recall if they had ever heard terms before if or if they had heard within a certain period of time? first paper of its kind. The aim of this article is to address how to best communicate the concept of overdiagnosis by displaying results from the first observational study in UK on this topic. This topic is of great interest considering the increasing debate on the significance and implications of overdiagnosis. The authors describe the study research question, and used research design as well as sampling procedure clearly and comprehensively. Considering the described sampling procedure and the representative national sample, this study has great potential to answer the important research question on how to better communicate the term 'overdiagnosis'. The manuscript is well written and easy to follow.
Nevertheless we would like to bring a few points to the attention of the authors:
We think this paper as a whole would benefit from a more refined analysis in order to learn more about the different groups in society and how the term overdiagnosis is understood or rather misunderstood. For example group comparisons -considering the demographic variables (i.e. gender, age, education, social class, etc.) or multivariate analysis could contribute to a better understanding of which groups in society understand the term 'overdiagnosis' and who misunderstands the term. More specific results could offer more precise implication on how the term could be better communicated to the general population, and if the different demographic groups in society should be addressed differently. It would also be interesting to see how the variables on "familiarity with screening information" relate to the understanding of the term 'overdiagnosis'. We think that more detailed analysis could lead to more precise results to better address the initial research question on how the concept of overdiagnosis could be communicated better.
1.
The authors suggest that this paper is helping to fill a gap in the literature-namely, we do not know how best to communicate about overdiagnosis. I agree that this is a real concern, and yet I'm not sure if this paper really contributes to our understanding here. The authors suggest that the term "overdiagnosis" may be confusing, and so they sought to assess whether alternative descriptions might be preferable. But my understanding of the literature in this area-including previous studies published by these authors (see, for example, citations 7 and 9) and others (citations 6 and 11) -is that we already know that actual understanding of this term is limited. The aforementioned prior qualitative and textual analyses have suggested as much, which is why a recent study attempted to assess awareness of and reactions to a statement about (i.e., definition of) overdiagnosis (see Nagler RH, Fowler EF, Gollust SE, Women's awareness of and responses to messages about breast cancer overdiagnosis and overtreatment: Results from a 2016 national survey. Medical Care. 2017; 55(10): 879-885). Although I suppose it is conceivable that terms other than "overdiagnosis" might be more readily understood, I'm not sure there is strong theoretical reason to believe this would be the case. In short, the argument and motivation for this study-and how it moves the field forward-needs greater development.
2.
The authors removed references to cancer from the NHS leaflet prompts so that findings could be generalized beyond the breast and prostate cancer screening contexts presented in those leaflets. Although I can understand the line of thinking here, I do wonder if it might have made it even more difficult for participants to make sense of this information/the terms because there was no anchoring information-just a vague reference to "screening tests to check for illnesses." 3. Table 1 offers substantial demographic and clinical information on participants, some of which we know to be important predictors of awareness of and receptivity to overdiagnosis and overtreatment arguments (see Nagler et al. study) . Did the authors consider trying to explain the observed variation in familiarity with and endorsement of various terms (i.e., antecedents of familiarity and endorsement)?
A few methodological questions:
4.
I know descriptions of the survey and measures were published elsewhere, but I think the manuscript would benefit from a little more methodological detail (so that readers don't have to look up another study in order to understand the current study's measures, etc.). As far as the sample is concerned, it would be useful to have response rate and/or cooperation rate information. 5.
I do wonder about the endorsement measure's construct validity. Has this measure been used previously? If not, can the authors say something about how they developed the measure, and whether there is any evidence that it captures what it's intended to capture? One could imagine participants interpreting it in distinct ways…. 6.
The authors indicate that this study uses items from a larger survey (the ABACUS survey). To the extent that this survey included additional information on overdiagnosis and related concepts, it would be helpful to hear more about this content and the order in which questions appeared. It seems plausible that responses to earlier questions could have primed (or otherwise shaped) responses to the items assessed here. Thanks for the opportunity to review this manuscript. It addresses an important gap in the literature and certainly provides opportunities for additional scholarship to build upon findings. In particularly a more in depth qualitative analysis would be merited to better understand public perspectives.
VERSION 1 -AUTHOR RESPONSE

REVIEWERS' COMMENTS TO THE AUTHORS
AR: We agree with this point and reiterate that part of the impetus for this study came from findings in previous qualitative studies (e.g. 6,7). We agree that further qualitative work would be valuable, particularly as a means of generating potential communication strategies that could be tested in future quantitative studies.
Introduction -The first sentence is very unclear and should be removed or reworded. Who holds this growing concern? The public? AR: We have amended the first sentence to indicate this concern exists primarily among healthcare providers and policymakers.
Participants -Were the 3 demographic characteristics the only ones collected? What about ethnicity and education? These are certainly not exhaustive for representativeness and could be seen as a limitation, or acknowledged as one.
AR: We agree that the attributes used with the aim of achieving representativeness are not exhaustive. We have amended this section to provide the complete list of attributes and acknowledged this as a limitation in the Discussion. Table 2 , were they asked to recall if they had ever heard terms before if or if they had heard within a certain period of time?
Results -For
AR: We refer to the Measures: Main outcomes section in which we quote the wording of the relevant question: "The second outcome measure (familiarity) was: "Have you ever seen or heard any of the previous seven terms before today?"". We sincerely congratulate the authors on a paper that is remarkable both in terms of novelty and relevance. As far as we know, this is the first paper of its kind. The aim of this article is to address how to best communicate the concept of overdiagnosis by displaying results from the first observational study in UK on this topic. This topic is of great interest considering the increasing debate on the significance and implications of overdiagnosis. The authors describe the study research question, and used research design as well as sampling procedure clearly and comprehensively. Considering the described sampling procedure and the representative national sample, this study has great potential to answer the important research question on how to better communicate the term 'overdiagnosis'. The manuscript is well written and easy to follow. AR: We thank the reviewers for their positive comments regarding the originality and significance of the study, and quality of the manuscript.
Nevertheless, we would like to bring a few points to the attention of the authors: We think this paper as a whole would benefit from a more refined analysis in order to learn more about the different groups in society and how the term overdiagnosis is understood or rather misunderstood. For example group comparisons -considering the demographic variables (i.e. gender, age, education, social class, etc.) or multivariate analysis could contribute to a better understanding of which groups in society understand the term 'overdiagnosis' and who misunderstands the term. More specific results could offer more precise implication on how the term could be better communicated to the general population, and if the different demographic groups in society should be addressed differently.
AR: We agree that analyses of familiarity with and endorsement of terms are relevant. Indeed, prior to submission, previous iterations of the manuscript included additional exploratory analyses broadly consistent with the reviewers' recommendation. These were omitted for the initial submission for the purposes of succinctness and in order to focus on the main study findings (i.e. that familiarity with/endorsement of terms was generally low without a clearly superior label). Given the strong endorsement of multivariable analyses by Reviewers 2 and Reviewer 3, we have reinstated a revised version of them and amended the paper accordingly.
The analyses assess predictors of i) familiarity with at least one term and ii) endorsement of at least one term as making sense, rather than testing familiarity with/endorsement of specific terms such as 'overdiagnosis'. We made this decision for two reasons. First, the distribution of results was essentially bimodal for both familiarity and endorsement (e.g. most participants either endorsed none of the suggested terms, or endorsed all of the suggested terms). Similarly, responses for each term were highly correlated. For example, among participants who endorsed 'overdiagnosis' as making sense as a label for the given description, the proportions who also endorsed each of the other specific terms as making sense (i.e. from 'overdetection' to 'false positive test results') ranged from 69% to 82%. Conversely, among participants who did not endorse 'overdiagnosis' as making sense as a label (i.e. responding "no" or "not sure"), the large majority did not endorse any other given term; concordance ranged from 80.4% to 93.0%.
In our view, this suggests there was relatively little justification for assessing predictors of familiarity with/endorsement of any specific term(s). Instead, we think it is more meaningful to assess predictors of familiarity/endorsement in aggregate.
It would also be interesting to see how the variables on "familiarity with screening information" relate to the understanding of the term 'overdiagnosis'. We think that more detailed analysis could lead to more precise results to better address the initial research question on how the concept of overdiagnosis could be communicated better.
AR: We agree with this suggestion; we have included predictor variables on familiarity with screening information as part of the analyses described above (e.g. having previously read a screening leaflet, or read or heard similar information).
Furthermore, the authors used the information leaflets of the Breast Cancer Screening Programme and Prostate Cancer Management Programme. Since not all readers are familiar with these programmes, it would be helpful, to add some basic information about the programmes.
AR: We have amended the Methods: Design section to provide additional detail on the nature of these Programmes.
In summary, we congratulate the authors for bringing attention to this important and unique research topic. This study examines public familiarity with and endorsement of terms used to describe overdiagnosis. Although this is a well-written discussion of an important topic, I do have some questions about the study's contribution to the growing literature. These questions, along with some additional points, are summarized below.
1.
AR: We agree with the reviewer's interpretation of the literature with respect to findings that public understanding of the term is limited and accept that the justification for the present study was not elaborated on sufficiently. We have revised the introduction to describe some of the key findings from previous research, how these support the study premise, and how this study builds on previous work.
2.
The authors removed references to cancer from the NHS leaflet prompts so that findings could be generalized beyond the breast and prostate cancer screening contexts presented in those leaflets. Although I can understand the line of thinking here, I do wonder if it might have made it even more difficult for participants to make sense of this information/the terms because there was no anchoring information-just a vague reference to "screening tests to check for illnesses." AR: We agree that we are unable to rule out this possibility. However, we would not necessarily hypothesise that this is the case: previous studies have been consistent in demonstrating that information on overdiagnosis is challenging for the public to understand, irrespective of whether it is presented in the context of cancer screening (e.g. 11) or healthcare in general (e.g. 9, 10). This does not suggest that anchoring information around a specific disease would have made an appreciable different to results.
3. Table 1 offers substantial demographic and clinical information on participants, some of which we know to be important predictors of awareness of and receptivity to overdiagnosis and overtreatment arguments (see Nagler et al. study) . Did the authors consider trying to explain the observed variation in familiarity with and endorsement of various terms (i.e., antecedents of familiarity and endorsement)? AR: Per our response to Reviewers 2, we have added exploratory analyses testing possible predictors of familiarity and endorsement.
4.
I know descriptions of the survey and measures were published elsewhere, but I think the manuscript would benefit from a little more methodological detail (so that readers don't have to look up another study in order to understand the current study's measures, etc.). As far as the sample is concerned, it would be useful to have response rate and/or cooperation rate information. AR: We have added additional methodological detail in the methods. In particular, these include the eligibility for questions on screening participation and methods of coding predictor variables. We have AR: We thank the reviewer for highlighting their work, which is clearly highly relevant to our study. We have added a paragraph in the Discussion to cover this, in which we suggest that the generally low levels of endorsement of different terms in the present study may have been the result of limited belief in and agreement with information about the concept described. We have also moved a point that was previously described as a limitation to this paragraph, in which we acknowledge that comprehension (and, per Nagler et al., acceptance) of information on overdiagnosis/overtreatment may differ when provided with more context. OTHER COMMENTS Authors' note for the editorial team: We would like to point out that we have made minor edits for grammar and style throughout the manuscript. All changes have been tracked.
